Raised plasma renin and prorenin in rheumatoid vasculitis. 1990

M Boers, and F C Breedveld, and B A Dijkmans, and P C Chang, and P van Brummelen, and F H Derkx, and A Cats
Department of Rheumatology, Leiden University Hospital, The Netherlands.

The value of plasma renin and its inactive precursor, prorenin, were examined as a marker for vasculitis in rheumatoid arthritis (RA). Plasma renin and prorenin rise when the renin-angiotensin system is activated; an isolated increase of prorenin may be a marker for microvascular complications in diabetes mellitus. Renin concentrations in plasma obtained from 34 patients with RA (seven with vasculitis, 27 controls) were measured under standard conditions, before and five days after stopping non-steroidal anti-inflammatory drugs; creatinine clearance was also measured. At first the median renin concentration in the patients with vasculitis was 19 (range 12-63) mU/l (normal less than 61 mU/l) and in the controls 9 (3-43) mU/l. The median prorenin concentration in patients with vasculitis was 233 (144-428) mU/l (normal less than 358 mU/l) and in the controls 144 (25-364) mU/l. Renin and prorenin concentrations increased significantly in both groups after withdrawal of nonsteroidal anti-inflammatory drugs. The creatinine clearance was similar in both groups and did not correlate with renin concentrations. In conclusion, it was found that, unlike patients with diabetes mellitus, patients with RA with vasculitis had slightly raised concentrations of both renin and prorenin. These findings signal activation of the renin-angiotensin system and might indicate early cardiac or renal involvement by vasculitis.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D003080 Cold Temperature An absence of warmth or heat or a temperature notably below an accustomed norm. Cold,Cold Temperatures,Temperature, Cold,Temperatures, Cold
D004792 Enzyme Precursors Physiologically inactive substances that can be converted to active enzymes. Enzyme Precursor,Proenzyme,Proenzymes,Zymogen,Zymogens,Precursor, Enzyme,Precursors, Enzyme
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D014657 Vasculitis Inflammation of any one of the blood vessels, including the ARTERIES; VEINS; and rest of the vasculature system in the body. Angiitis,Angiitides,Vasculitides

Related Publications

M Boers, and F C Breedveld, and B A Dijkmans, and P C Chang, and P van Brummelen, and F H Derkx, and A Cats
October 1991, Clinical chemistry,
M Boers, and F C Breedveld, and B A Dijkmans, and P C Chang, and P van Brummelen, and F H Derkx, and A Cats
October 1977, Circulation research,
M Boers, and F C Breedveld, and B A Dijkmans, and P C Chang, and P van Brummelen, and F H Derkx, and A Cats
October 1988, American journal of diseases of children (1960),
M Boers, and F C Breedveld, and B A Dijkmans, and P C Chang, and P van Brummelen, and F H Derkx, and A Cats
March 1990, American journal of hypertension,
M Boers, and F C Breedveld, and B A Dijkmans, and P C Chang, and P van Brummelen, and F H Derkx, and A Cats
April 1982, Mineral and electrolyte metabolism,
M Boers, and F C Breedveld, and B A Dijkmans, and P C Chang, and P van Brummelen, and F H Derkx, and A Cats
May 1996, Immunopharmacology,
M Boers, and F C Breedveld, and B A Dijkmans, and P C Chang, and P van Brummelen, and F H Derkx, and A Cats
February 1988, The Journal of clinical endocrinology and metabolism,
M Boers, and F C Breedveld, and B A Dijkmans, and P C Chang, and P van Brummelen, and F H Derkx, and A Cats
August 2004, Placenta,
M Boers, and F C Breedveld, and B A Dijkmans, and P C Chang, and P van Brummelen, and F H Derkx, and A Cats
November 1987, Canadian journal of physiology and pharmacology,
M Boers, and F C Breedveld, and B A Dijkmans, and P C Chang, and P van Brummelen, and F H Derkx, and A Cats
December 2008, Hypertension (Dallas, Tex. : 1979),
Copied contents to your clipboard!